BACKGROUND: Despite the effectiveness of antiretroviral therapy, nearly half of patients entering human immunodeficiency virus (HIV) care have advanced disease. Many attribute this delay to poor access to healthcare. Others argue that delays will persist until routine screening is adopted. The Veterans Health Administration (VA) is a unique laboratory to examine whether access to comprehensive health benefits results in earlier entry into HIV care. METHODS: Retrospective observational study of 4368 HIV-positive patients entering HIV care during 1998-2002 at VA medical centers nationwide. OUTCOMES OF INTEREST: rates of acquired immune deficiency syndrome in year of presentation; duration of VA utilization before HIV presentation; presence of "clinical triggers," signaling greater risk of HIV infection, before presentation. RESULTS: Fifty-one percent (n = 2211) of all patients presented with CD4 counts of < 200 cells/mm. Thirty-nine percent (n = 1697) of all patients used other VA services before presentation for HIV care, with median duration of 3.6 years (interquartile range 25-75: 2.2-5.1 year) and 6 physician visits [interquartile range (IQR), 25-75: 2-18 visits] between first utilization and HIV presentation. No difference existed in the percentage presenting with CD4 counts <200 cells/mm among those with and without prior VA healthcare (50% vs. 51%, P = 0.76). Only 13% of those with prior VA healthcare demonstrated a clinical trigger before HIV presentation. CONCLUSIONS: More than half of veterans entered HIV care with an acquired immune deficiency syndrome diagnosis at presentation irrespective of whether they had previously established healthcare in the VA. Access to care does not seem to be the primary cause of delayed HIV presentation. Widespread HIV screening is needed to improve rates of early detection.
BACKGROUND: Despite the effectiveness of antiretroviral therapy, nearly half of patients entering human immunodeficiency virus (HIV) care have advanced disease. Many attribute this delay to poor access to healthcare. Others argue that delays will persist until routine screening is adopted. The Veterans Health Administration (VA) is a unique laboratory to examine whether access to comprehensive health benefits results in earlier entry into HIV care. METHODS: Retrospective observational study of 4368 HIV-positive patients entering HIV care during 1998-2002 at VA medical centers nationwide. OUTCOMES OF INTEREST: rates of acquired immune deficiency syndrome in year of presentation; duration of VA utilization before HIV presentation; presence of "clinical triggers," signaling greater risk of HIV infection, before presentation. RESULTS: Fifty-one percent (n = 2211) of all patients presented with CD4 counts of < 200 cells/mm. Thirty-nine percent (n = 1697) of all patients used other VA services before presentation for HIV care, with median duration of 3.6 years (interquartile range 25-75: 2.2-5.1 year) and 6 physician visits [interquartile range (IQR), 25-75: 2-18 visits] between first utilization and HIV presentation. No difference existed in the percentage presenting with CD4 counts <200 cells/mm among those with and without prior VA healthcare (50% vs. 51%, P = 0.76). Only 13% of those with prior VA healthcare demonstrated a clinical trigger before HIV presentation. CONCLUSIONS: More than half of veterans entered HIV care with an acquired immune deficiency syndrome diagnosis at presentation irrespective of whether they had previously established healthcare in the VA. Access to care does not seem to be the primary cause of delayed HIV presentation. Widespread HIV screening is needed to improve rates of early detection.
Authors: F J Palella; K M Delaney; A C Moorman; M O Loveless; J Fuhrer; G A Satten; D J Aschman; S D Holmberg Journal: N Engl J Med Date: 1998-03-26 Impact factor: 91.245
Authors: Gillian D Sanders; Ahmed M Bayoumi; Vandana Sundaram; S Pinar Bilir; Christopher P Neukermans; Chara E Rydzak; Lena R Douglass; Laura C Lazzeroni; Mark Holodniy; Douglas K Owens Journal: N Engl J Med Date: 2005-02-10 Impact factor: 91.245
Authors: A David Paltiel; Milton C Weinstein; April D Kimmel; George R Seage; Elena Losina; Hong Zhang; Kenneth A Freedberg; Rochelle P Walensky Journal: N Engl J Med Date: 2005-02-10 Impact factor: 91.245
Authors: Amy C Justice; Elizabeth Dombrowski; Joseph Conigliaro; Shawn L Fultz; Deborah Gibson; Tamra Madenwald; Joseph Goulet; Michael Simberkoff; Adeel A Butt; David Rimland; Maria C Rodriguez-Barradas; Cynthia L Gibert; Kris Ann K Oursler; Sheldon Brown; David A Leaf; Matthew B Goetz; Kendall Bryant Journal: Med Care Date: 2006-08 Impact factor: 2.983
Authors: Neel R Gandhi; Janet P Tate; Maria C Rodriguez-Barradas; David Rimland; Matthew Bidwell Goetz; Cynthia Gibert; Sheldon T Brown; Kristin Mattocks; Amy C Justice Journal: Pharmacoepidemiol Drug Saf Date: 2013-07-09 Impact factor: 2.890
Authors: Véronique Joly; Catherine Fagard; Carine Grondin; Diane Descamps; Yazdan Yazdanpanah; Charlotte Charpentier; Nathalie Colin de Verdiere; Sophie Tabuteau; François Raffi; André Cabie; Geneviève Chene; Patrick Yeni Journal: Antimicrob Agents Chemother Date: 2012-11-19 Impact factor: 5.191
Authors: Susie Hoffman; Yingfeng Wu; Maria Lahuerta; Sarah Gorrell Kulkarni; Harriet Nuwagaba-Biribonwoha; Wafaa El Sadr; Robert H Remien; Veronicah Mugisha; Mark Hawken; Ema Chuva; Denis Nash; Batya Elul Journal: AIDS Date: 2014-10-23 Impact factor: 4.177
Authors: Michael Ohl; Janet Tate; Mona Duggal; Melissa Skanderson; Matthew Scotch; Peter Kaboli; Mary Vaughan-Sarrazin; Amy Justice Journal: Med Care Date: 2010-12 Impact factor: 2.983
Authors: Monisha Arya; Amber L Bush; Michael A Kallen; Maria C Rodriguez-Barradas; Thomas P Giordano Journal: Mil Med Date: 2013-04 Impact factor: 1.437
Authors: Engi F Attia; Kathleen M Akgün; Cherry Wongtrakool; Matthew Bidwell Goetz; Maria C Rodriguez-Barradas; David Rimland; Sheldon T Brown; Guy W Soo Hoo; Joon Kim; Patty J Lee; Lynn M Schnapp; Amir Sharafkhaneh; Amy C Justice; Kristina Crothers Journal: Chest Date: 2014-12 Impact factor: 9.410
Authors: Joseph L Goulet; Shawn L Fultz; David Rimland; Adeel Butt; Cynthia Gibert; Maria Rodriguez-Barradas; Kendall Bryant; Amy C Justice Journal: Clin Infect Dis Date: 2007-12-15 Impact factor: 9.079
Authors: Sharon B Mannheimer; Lei Wang; Leo Wilton; Hong Van Tieu; Carlos Del Rio; Susan Buchbinder; Sheldon Fields; Sara Glick; Matthew B Connor; Vanessa Cummings; Susan H Eshleman; Beryl Koblin; Kenneth H Mayer Journal: J Acquir Immune Defic Syndr Date: 2014-12-01 Impact factor: 3.731
Authors: Keri N Althoff; Kate Buchacz; H Irene Hall; Jinbing Zhang; David B Hanna; Peter Rebeiro; Stephen J Gange; Richard D Moore; Mari M Kitahata; Kelly A Gebo; Jeffrey Martin; Amy C Justice; Michael A Horberg; Robert S Hogg; Timothy R Sterling; Angela Cescon; Marina B Klein; Jennifer E Thorne; Heidi M Crane; Michael J Mugavero; Sonia Napravnik; Gregory D Kirk; Lisa P Jacobson; John T Brooks Journal: Ann Intern Med Date: 2012-09-04 Impact factor: 25.391